ChemDiv

Executive Summary

ChemDiv, Inc. is a fully integrated contract research organization (CRO) headquartered in San Diego, specializing in small molecule drug discovery and development since its founding in 1990. The company offers a comprehensive suite of services spanning from target identification to clinical proof-of-concept, supported by extensive compound libraries and a hybrid AI/ML technology platform. With over three decades of experience, ChemDiv has established itself as a reliable partner for pharmaceutical and biotechnology companies seeking to accelerate their drug discovery programs. The company's integrated approach, combining cutting-edge computational tools with traditional medicinal chemistry, positions it well to address the growing demand for efficient and cost-effective drug development solutions. As a private company currently in the Phase 1 stage, ChemDiv is poised to capitalize on the increasing outsourcing trend in the pharmaceutical industry, particularly in the small molecule space where its core competencies lie.

Upcoming Catalysts (preview)

• Q4 2026Announcement of Major Partnership with Top Pharma Company40% success
• Q2 2026Launch of Next-Generation AI/ML Drug Discovery Platform75% success
• Q1 2027Milestone Achievement in Proprietary Drug Candidate Program55% success